IceCure Medical Ltd. Promotes Shay Levav to COO
Ticker: ICCM · Form: 6-K · Filed: Nov 10, 2025 · CIK: 1584371
Sentiment: neutral
Topics: management-change, promotion
TL;DR
IceCure Medical just promoted Shay Levav to COO, effective Nov 5th.
AI Summary
On November 5, 2025, IceCure Medical Ltd. announced the promotion of Shay Levav from Vice President of Regulatory and Quality Assurance and Clinical Applications to Chief Operating Officer. Levav has been with the company since September 2020.
Why It Matters
This internal promotion signals a potential shift in operational focus or leadership structure within IceCure Medical Ltd.
Risk Assessment
Risk Level: low — The filing is a routine management change announcement with no immediate financial implications.
Key Players & Entities
- IceCure Medical Ltd. (company) — The company making the announcement.
- Shay Levav (person) — The individual promoted to Chief Operating Officer.
- November 5, 2025 (date) — The effective date of the management change.
- September 2020 (date) — The date Shay Levav joined the company in his previous role.
FAQ
What was Shay Levav's previous role at IceCure Medical Ltd.?
Shay Levav previously served as the Company's Vice President of Regulatory and Quality Assurance and Clinical Applications.
When was the promotion of Shay Levav approved?
The promotion of Shay Levav was approved by the Board of Directors on November 5, 2025.
What is the new role for Shay Levav?
Shay Levav has been promoted to the position of Chief Operating Officer.
Since when has Shay Levav been associated with IceCure Medical Ltd. in his previous capacity?
Shay Levav had been serving as the Company's Vice President of Regulatory and Quality Assurance and Clinical Applications since September 2020.
What is the filing type and date?
This is a Form 6-K filed on November 10, 2025.
Filing Stats: 442 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2025-11-10 08:45:15
Filing Documents
- ea0264338-6k_icecure.htm (6-K) — 13KB
- ea026433801ex99-1_icecure.htm (EX-99.1) — 10KB
- 0001213900-25-107921.txt ( ) — 25KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ICECURE MEDICAL LTD. Date: November 10, 2025 By: /s/ Eyal Shamir Name: Eyal Shamir Title: Chief Executive Officer 2